Cian Healthcare Ltd

Cian Healthcare Limited was originally incorporated as a Private Limited Company with the name of 'Cian Healthcare Private Limited' on January 07, 2003. Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to 'Cian Healthcare Limited' pursuant to a fresh Certificate of Incorporation granted by the Registrar of Companies, Pune dated November 30, 2018. The Company is a certified transnational manufacturing Company with wide range of Pharmaceutical, Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness and Food supplement products. The Company complies with the standard manufacturing practices as laid down by the World Health Organization and is also certified by the Food and Drug Control Administration. The Company started manufacturing unit at Roorkee in Uttarakhand in 2013. It works under different business models like Brand Business, Export, Third Party Manufacturing and Government Supplies. In May 2019, the Company came up with a Public Issue of 62,16,000 Equity Shares. The Company has product approvals under the license issued by Drug Controlling & Licensing Authority Uttarkhand, for manufacturing of Tablets, Capsules, Oral Liquids and Ointments and also for analysis of Chemical, Instrumental & Microbiology. It manufactures innovative products comprising of Tablets, Capsules, Liquid Orals, Ointments, Creams, Lotions, Gels and Sachet. The Company has special licence for manufacturing veterinary products for client like SAVAvet and Venky's. Cian developed more than 1,000 formulations and 2000 brands for domestic market under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals. Subsequent to the Corporate Insolvency Resolution Process (CIRP) commenced against the Company vide an order passed by Hon'ble National Company Law Tribunal, Mumbai Bench (NCLT) dated August 14, 2024, the operations of the Company have been affected due to the initiation of CIRP, however the company is still operative and has generated losses during the year 2024-25.